author-photo

Michael Belcourt

Vion Pharmaceuticals, Inc.

13

Papers

165

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Reduced level of ribonucleotide reductase R2 subunits increases dependence on homologous recombination repair of cisplatin-induced DNA damage.

2011 Molecular Pharmacology
Show All
- Source
- Cite
- Save
Citations (18)
The in vivo therapeutic efficacy of R-KS119W (VNP40541) in combination with conventional anti-cancer agents

2006 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
The in vivo selection of the R-enantiomer of KS119W (VNP40541) as a potential anticancer agent

2006 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Anti-tumor activity of the heterocyclic hydrazones (HCHs), A new class of experimental antitumor agent

2006 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
The in vivo selection of the R-enantiomer of KS119W (VNP40541) as a potential anticancer agent

2006 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Combination of KS119W with other antitumor agents for the treatment of murine and human tumor xenografts in mice

2005 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Selective killing of hypoxic tumor cells by water soluble analogs of 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119)

2005 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Tumor-Targeted Salmonella Expressing Cytosine Deaminase as an Anticancer Agent

2002 Human Gene Therapy
Show All
- Source
- Cite
- Save
Citations (93)
Verbindungen und methoden zum tumorgerichteten transport von effektormolekülen

2000
Show All
- Source
- Cite
- Save
Citations (0)